These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 817635)

  • 1. Biochemical characteristics of middle ear effusions.
    Juhn SK; Huff JS
    Ann Otol Rhinol Laryngol; 1976; 85(2 Suppl 25 Pt 2):110-6. PubMed ID: 817635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Certain oxidative and hydrolytic enzymes in the middle ear effusion in serous otitis media.
    Juhn SK; Huff JS; Paparella MM
    Arch Otorhinolaryngol; 1976 May; 212(2):119-25. PubMed ID: 989718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical analyses of middle ear effusions.
    Juhn SK; Huff JS; Paparella MM
    Ann Otol Rhinol Laryngol; 1971 Jun; 80(3):347-53. PubMed ID: 4105579
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunologic aspects of otitis media with effusion.
    Mogi G; Watanabe N; Maeda S; Umehara T
    Acta Otorhinolaryngol Belg; 1983; 37(1):5-21. PubMed ID: 6351530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical and immunochemical characteristics of middle ear effusions in relation to bacteriological findings.
    Juhn SK; Giebink GS; Huff JS; Mills EL
    Ann Otol Rhinol Laryngol Suppl; 1980; 89(3 Pt 2):161-7. PubMed ID: 6778300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysosomal hydrolases in middle ear effusions.
    Diven WF; Glew RH; Bluestone CD
    Ann Otol Rhinol Laryngol; 1981; 90(2 Pt 1):148-53. PubMed ID: 7224513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydrolase activity in acute otitis media with effusion.
    Diven WF; Glew RH; LaMarco KL
    Ann Otol Rhinol Laryngol; 1985; 94(4 Pt 1):415-8. PubMed ID: 4040728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lactate dehydrogenase activity and isoenzyme patterns in serous middle ear effusions.
    Juhn SK; Huff JS; Paparella MM
    Ann Otol Rhinol Laryngol; 1973; 82(2):192-5. PubMed ID: 4702355
    [No Abstract]   [Full Text] [Related]  

  • 9. Chronic serous otitis media: an immune complex disease.
    Maxim PE; Veltri RW; Sprinkle PM; Pusateri RJ
    Trans Sect Otolaryngol Am Acad Ophthalmol Otolaryngol; 1977; 84(2):234-8. PubMed ID: 143103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of prostaglandin on the composition of chinchilla middle ear effusion.
    Jung TT; Smith DM; Juhn SK; Gerrard JM
    Ann Otol Rhinol Laryngol Suppl; 1980; 89(3 Pt 2):153-60. PubMed ID: 6778299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Otitis media: the middle ear effusion total white cell count.
    Ostfeld E
    Am J Otol; 1984 Jul; 5(5):382-6. PubMed ID: 6540996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The kinetics of penicillin diffusion in serum and middle ear effusions in experimentally induced otitis media.
    Juhn SK; Edlin J; Jung TT; Giebink GS
    Arch Otorhinolaryngol; 1986; 243(3):183-5. PubMed ID: 3753296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell adhesion molecules and cytokines in middle ear effusions in children with or without recent acute otitis media.
    Russo E; Smith CW; Friedman EM; Smith EO; Kaplan SL
    Otolaryngol Head Neck Surg; 2004 Feb; 130(2):242-8. PubMed ID: 14990922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequential analysis of serum proteins in middle ear effusions. A study in rats with experimentally induced serous and purulent otitis media.
    Johansson U; Hellström S; Stenfors LE; Stigbrand T
    Eur Arch Otorhinolaryngol; 1990; 248(2):63-7. PubMed ID: 2282215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Granulocyte protease inhibition in acute and chronic middle ear effusion.
    Carlsson B; Lundberg C; Ohlsson K
    Acta Otolaryngol; 1983; 95(3-4):341-9. PubMed ID: 6188318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycoprotein analysis of middle ear effusions by rectin-conjugated sepharose affinity chromatography.
    Sakakura K; Hamaguchi Y; Majima Y; Ukai K; Sakakura Y
    Arch Otorhinolaryngol; 1986; 243(4):224-8. PubMed ID: 3778295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytological and immunochemical characterization of middle ear effusions: an experimental approach.
    Stenfors LE; Hellström S; Angström T; Johansson U
    Auris Nasus Larynx; 1985; 12 Suppl 1():S83-5. PubMed ID: 3835945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secretory IgA and antibody activities in middle ear effusions.
    Mogi G
    Ann Otol Rhinol Laryngol; 1976; 85(2 Suppl 25 Pt 2):97-102. PubMed ID: 1267375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activities of antiplasmin and antiplasminogen activator in serous middle ear effusions.
    Hamaguchi Y; Ohi M; Sakakura Y; Miyoshi Y
    Ann Otol Rhinol Laryngol; 1985; 94(3):293-6. PubMed ID: 3925865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma component of middle ear effusion evaluated by prekallikrein level.
    Hamaguchi Y; Sakakura Y; Majima Y; Ukai K; Miyoshi Y
    ORL J Otorhinolaryngol Relat Spec; 1985; 47(3):145-50. PubMed ID: 3846864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.